Business Wire

L&T-TECHNOLOGY-SERVICES

1.2.2024 05:45:26 CET | Business Wire | Press release

Share
L&T Technology Services supports Marelli in Revolutionizing Automotive Infotainment with Digital Twin Technology

L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a leading global digital engineering and R&D services company, supports Marelli, a leading mobility technology supplier to the automotive sector in redefining the landscape of automotive infotainment and information cluster design through the introduction of Marelli’s groundbreaking Digital Twin solutions. By harnessing the power of these innovative solutions, Marelli – supported by LTTS – has drastically streamlined automotive software development processes and reduced prototype costs, heralding a new era in the automotive industry for the development of Software Defined Vehicles (SDV).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240130254637/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Marelli's Digital Twin with the support of LTTS, offers a virtual replica of the entire car electric-electronic architecture - from information cluster to infotainment. (Graphic: Business Wire)

Built on Amazon Web Services (AWS), with the support of LTTS, Marelli's Digital Twin provides a virtual replica of the entire car electric-electronic architecture - from information clusters to infotainment, and from Zone Control Units to body. Leveraging Digital Cockpit that runs on the latest generation Snapdragon® Cockpit Platform from Qualcomm Technologies, Inc. and LTTS cloud-based virtualization solutions, Marelli's Digital Twin streamlines software development and prototype creation, cutting costs and accelerating timelines. This innovative solution is set to revolutionize the automotive industry, significantly reducing software development time by up to 70% and prototype costs by up to 30%.

The groundbreaking solution was showcased at the Consumer Electronics Show (CES) 2024, held in Las Vegas in January 2024.

“We are excited to join forces with LTTS in our ongoing efforts to enhance our Digital Twin,” expressed Roberto Secchi, Head of Software Platform and DevOps at Marelli’s Electronic Systems division. “Marelli has become a key player in the SDV arena, thanks to our dedicated investments and the exploration of various business prospects, all driven by our unwavering commitment to innovation. Leveraging LTTS’ capabilities will further boost our product portfolio, reinforcing Marelli as the premier technology partner for automotive companies.”

"We are thrilled to embark on a strategic collaboration with Marelli, leveraging the vast capabilities of software defined mobility, Digital Cockpit systems, connected cars to bolster Marelli's vision to revolutionize the future of mobility," said Abhishek Sinha, Chief Operating Officer and Board Member at L&T Technology Services. "This partnership is not only catalyzing unparalleled efficiencies in automotive software development but also spearheading the future of automotive infotainment through our groundbreaking digital twin offerings. Together, we are pioneering a new era of innovation, setting the stage for the next generation of mobility solutions."

Snapdragon is a trademark or registered trademarks of Qualcomm Incorporated.
Snapdragon is a product of Qualcomm Technologies, Inc. and/or its subsidiaries.

About L&T Technology Services Ltd

L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 57 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 23,200 employees spread across 22 global design centers, 28 global sales offices and 105 innovation labs as of December 31, 2023. For more information, please visit https://www.LTTS.com/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240130254637/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 20266.5.2026 12:30:00 CEST | Press release

Compass management will host a conference call at 8:00 am ET (1:00 pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter ended March 31, 2026, and provide an update on recent developments, on May 13, 2026. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on May 13, 2026. A live webcast of the call will be available on the Compass Pathways website at: https://events.q4inc.com/attendee/144892287. The webcast will be archived for 30 days. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new p

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)6.5.2026 12:25:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to thirteen newly hired non-executive employees. The equity awards were granted on May 1, 2026 and consisted of options to purchase an aggregate of 125,335 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 59,625 shares. The options have an exercise price per share equal to $9.01, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Aircall Acquires Vogent to Advance Its AI Voice Agent Built Natively into Business Phones6.5.2026 12:03:00 CEST | Press release

Aircall, the AI-powered customer communications platform trusted by more than 22,000 businesses worldwide, today announced the acquisition of Vogent, an AI voice agent company. The acquisition adds a new layer of specialized voice AI technology to Aircall’s platform – strengthening the technology behind Aircall’s AI Voice Agent and moving it from already great to best-in-class. While AI agents' chat or email based communication channels have exploded in popularity, voice is its own discipline – with unique demands around timing, interruption handling, call flows, and production reliability. Voice channel also comes with the highest expectations from customers, further putting scrutiny around the readiness of the technology. For many businesses deploying AI voice agents, the experience has not lived up to the hype. With Vogent, Aircall enhances its AI Voice Agents with a deeper set of specialized AI technologies, including advanced speech models, more reliable turn-taking, and higher pr

AB InBev Wins Cannes Lions Creative Marketer of the Year for an Unprecedented Third Time6.5.2026 12:03:00 CEST | Press release

The world’s leading brewer’s approach to creativity as a competitive advantage results in strong performance and increased revenues The Cannes Lions International Festival of Creativity has announced AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD) as the 2026 Creative Marketer of the Year. The honorary accolade is presented to a marketer that has amassed a body of iconic, Lion-winning work over a sustained period of time. AB InBev’s continued commitment to using creativity as a growth lever across its portfolio resulted in it winning an impressive 37 Lions at last year’s Festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506536538/en/ AB InBev is the first company in Cannes Lions’ history to be honoured with the award for a third time. Since 2021 the global brewer has embarked on a journey of inorganic to organic growth, betting on creativity as a key competitive advantage that has contributed to strong perfor

BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates6.5.2026 12:00:00 CEST | Press release

Total global revenues of $1.5 billion for the first quarter, an increase of 35% from the prior year Foundational BRUKINSA (zanubrutinib) global revenues of $1.1 billion for the first quarter, an increase of 38% from the prior year Diluted GAAP Earnings per American Depository Share (ADS) of $1.96 for the first quarter; non-GAAP diluted Earnings per ADS of $3.24 for the first quarter BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the first quarter of 2026. John V. Oyler, Co-Founder, Chairman, and CEO, BeOne, said: “These strong first-quarter results reinforce BeOne’s continued growth as a global oncology leader, driven by disciplined commercial execution, and underpinned by our established hematology leadership, and an impressive, rapidly emerging solid tumor pipeline. The sustained competitive advantages of our global superhighway for clinical development and manufacturing are now cle

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye